NON-SMALL-CELL LUNG
Clinical trials for NON-SMALL-CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL-CELL LUNG trials appear
Sign up with your email to follow new studies for NON-SMALL-CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lung cancer drug shows promise in Early-Stage trial
Disease control Not yet recruitingThis study tests a new medicine, PF-08634404, given alone or with chemotherapy for adults with early or locally advanced non-small cell lung cancer. The goal is to see if it can shrink tumors before surgery or prevent cancer from returning after treatment. About 120 participants …
Matched conditions: NON-SMALL-CELL LUNG
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 04:31 UTC
-
Massive review to uncover how lung cancer is treated in china
Knowledge-focused Not yet recruitingThis study will look back at medical records of 3000 people in China with early-stage non-small cell lung cancer (stages I to III). The goal is to understand which treatments doctors use, how often biomarker testing is done, and what happens to patients over time. No new treatmen…
Matched conditions: NON-SMALL-CELL LUNG
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC
-
Real-World data to reveal how lung cancer drug lorlatinib performs outside clinical trials
Knowledge-focused Not yet recruitingThis study looks at how patients with a specific type of advanced lung cancer (ALK-positive non-small cell lung cancer) respond to the drug lorlatinib when it is used as their first treatment. Researchers will analyze information from a large database of 200 patients to see how l…
Matched conditions: NON-SMALL-CELL LUNG
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC